Effect of antidiabetic agents added to metformin on glycaemic control, hypoglycaemia and weight change in patients with type 2 diabetes: a network meta-analysis.
about
Dipeptidyl peptidase-4 and kidney fibrosis in diabetesTreatment intensification in patients with inadequate glycemic control on basal insulin: rationale and clinical evidence for the use of short-acting and other glucagon-like peptide-1 receptor agonistsMedical Management of Diabesity: Do We Have Realistic Targets?Efficacy and safety of insulin-GLP-1 receptor agonists combination in type 2 diabetes mellitus: a systematic review.Indirect comparison of lixisenatide versus neutral protamine Hagedorn insulin as add-on to metformin and sulphonylurea in patients with type 2 diabetes mellitus.Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities.A real world comparison of sulfonylurea and insulin vs. incretin-based treatments in patients not controlled on prior metformin monotherapy.Observational and clinical trial findings on the comparative effectiveness of diabetes drugs showed agreement.Glycaemic control efficacy of oral antidiabetic drugs in treating type 2 diabetes: a protocol for network meta-analysis.Incretin-based medications for type 2 diabetes: an overview of reviews.Diabetes treatment intensification and associated changes in HbA1c and body mass index: a cohort study.Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trialsAchieving "PeaK-A" insulin secretionTreatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries.Medication usage, treatment intensification, and medical cost in patients with type 2 diabetes: a retrospective database studyClinical practice guideline for the prevention, early detection, diagnosis, management and follow up of type 2 diabetes mellitus in adults.Activation of AMPK attenuates LPS-induced acute lung injury by upregulation of PGC1α and SOD1.Effect of insulin degludec versus sitagliptin in patients with type 2 diabetes uncontrolled on oral antidiabetic agents.The Effectiveness of Myo-Inositol and D-Chiro Inositol Treatment in Type 2 Diabetes.Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015.The treatment of type 2 diabetes.Cardiovascular effects of gliptins.Linagliptin plus metformin: a pharmacokinetic and pharmacodynamic evaluation.Cardiovascular effects of dipeptidyl peptidase-4 inhibitors: from risk factors to clinical outcomes.Head-to-head comparison of dipeptidyl peptidase-IV inhibitors and sulfonylureas - a meta-analysis from randomized clinical trials.The safety of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter 2 (SGLT-2) inhibitors added to metformin background therapy in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.Dipeptidyl peptidase-4 inhibitors can minimize the hypoglycaemic burden and enhance safety in elderly people with diabetes.DPP4 in cardiometabolic disease: recent insights from the laboratory and clinical trials of DPP4 inhibition.Clinical Management of Type 2 Diabetes Mellitus after Bariatric Surgery.Development of RP-HPLC, Stability Indicating Method for Degradation Products of Linagliptin in Presence of Metformin HCl by Applying 2 Level Factorial Design; and Identification of Impurity-VII, VIII and IX and Synthesis of Impurity-VII.Glucagon-like peptide-1 agonists combating clozapine-associated obesity and diabetes.Surgery in overweight patients with insulinoma: effects on weight loss.Clinical Pharmacokinetics and Pharmacodynamics of Saxagliptin, a Dipeptidyl Peptidase-4 Inhibitor.Hypoglycaemia when adding sulphonylurea to metformin: a systematic review and network meta-analysis.Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum.Analytical Enantio-Separation of Linagliptin in Linagliptin and Metformin HCl Dosage Forms by Applying Two-Level Factorial Design.Access to emergency room for hypoglycaemia in people with diabetes.Hypoglycemic activity of Pyrus biossieriana Buhse leaf extract and arbutin: Inhibitory effects on alpha amylase and alpha glucosidase.The Need for a Tool to Assist Health Care Professionals and Patients in Making Medication Treatment Decisions in the Clinical Management of Type 2 Diabetes.Energy loss via urine and faeces--a combustive analysis in diabetic rats and the impact of antidiabetic treatment on body weight.
P2860
Q26766089-8D112B39-82C3-4174-9759-C5503500173CQ28077026-F334073A-456C-4C44-AD52-E8DD5EA97F26Q30238940-7EF615C2-5AA0-4BE5-ACA6-B49BF1EFEC8CQ30240808-264FFDE7-8653-43A7-B07F-1780E6019E94Q34368524-FB487624-5578-4585-9149-273E7908255CQ34532529-4D722BE2-53EB-47BD-BDD8-F6483B5528DBQ35073584-34A8486D-F025-4692-83AA-29D8FC14642DQ35146648-09661295-5771-46CB-B7B4-F039B49ABB39Q35179679-3800B3CD-DFE6-4C6A-935C-711354147A8DQ35577601-F2F38F3F-E841-4ADA-ADA4-767814088EE5Q36038607-EBA73DF3-62CD-4F6C-B4B8-0F01A10D2454Q36071183-E3B108E4-249A-4D95-BCC8-0F71C41523F3Q36796114-2911C61C-04F8-4BD7-96E4-F905D54EC25CQ36833164-1226B165-66F1-4A15-9AFA-FE1FEA791427Q37133799-5E3BD0DD-8C49-41A5-8D51-089F9EA7389CQ37154927-8DEC01F9-8B13-4DE5-8958-64401A5FB289Q37204771-F29BE35A-5458-438E-A751-C9395E222882Q37236069-40830391-12D3-42C7-985F-AC7C698B33FDQ37363630-B443FDE0-BDBB-4474-AD9B-731D8BC23DCBQ37397867-11B35DAB-B48A-4891-ABD6-99D0AF8BCEA3Q37634244-D7138D13-15AD-4A16-89B6-4730D3D64E14Q38072259-9EB35B69-5864-4944-A857-7F7609E151D7Q38078436-DDEF63BC-1375-4BB5-810B-693CEFE702A5Q38113092-7410F5B9-CEA6-4ECF-BD9D-B2B6087A7985Q38152405-722056E1-C16F-4866-B9CC-249007C53106Q38211881-A258DB86-1023-4F98-9ECB-F9572ADE7477Q38215452-04301F98-07F9-4841-92E3-0B801DAD9935Q38413395-3BC1E50D-05DC-47B3-B139-31E959605875Q38572961-C997B4EA-1D19-446E-A79D-ACFA3EE0C9B5Q38707307-BEDCB573-3A34-4582-9852-01481E88D60DQ38708352-58FB34E0-F672-4596-9C76-05F77CD451F1Q38742852-7618F69F-6952-4C5C-9433-D77A3E4A59F9Q38860371-CD43C3D6-380B-4CC8-9F21-9BBBEFCEB1AEQ38899869-8E50C17F-8C08-4548-9829-D35A8A211856Q39413300-D05D0519-DAB3-4B7E-B080-CAD900B1CE09Q40243211-FAD1DA4C-CFD3-417D-A54F-75828A3FA911Q41692979-1474246A-2864-414E-A38F-B81690E9B603Q42865625-81BB2599-2272-4A01-BBC9-01DD1D303230Q43172161-A3F0DA88-0FA0-46AA-81BB-A28E055C7400Q44500493-1D9EA981-B572-4DC1-804B-AD4045CA8289
P2860
Effect of antidiabetic agents added to metformin on glycaemic control, hypoglycaemia and weight change in patients with type 2 diabetes: a network meta-analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Effect of antidiabetic agents ...... etes: a network meta-analysis.
@en
type
label
Effect of antidiabetic agents ...... etes: a network meta-analysis.
@en
prefLabel
Effect of antidiabetic agents ...... etes: a network meta-analysis.
@en
P2093
P2860
P921
P1476
Effect of antidiabetic agents ...... betes: a network meta-analysis
@en
P2093
P2860
P304
P356
10.1111/J.1463-1326.2012.01606.X
P50
P577
2012-04-29T00:00:00Z